Please upgrade your browser.
The National Institute for Health and Clinical Excellence has denied patients with kidney cancer access to Roches Avastin (bevacizumab), Bayers Nexavar (sorafenib) and Wyeths Torisel (temsirolimus) on the National Health Service.
The FDA granted orphan drug status to Oncophage as a brain cancer treatment, allowing up to 7 years of market exclusivity if approved for the indication.
"We had been aware of these issues before the FDA order and had them corrected before the FDA order," said Dr. John Sweetenham, head of research at the cancer center.
More than half of those surveyed believe agency is falling behind in safeguarding food, drugs.
Thousands of kidney cancer patients are likely to lose out on life-prolonging drugs.
Hey--anybody remember the origin of the phrase, "the 100 days"? If you guessed Franklin Roosevelt's burst of New Deal activism in 1933--you guessed wrong.
Hospital records are one thing, but online personal medical records are still a work in progress.
85-Year-Old Long Island Woman Cancer Free, Following 12-Hour Surgery to Remove Cancerous Kidney Tumor That Had Traveled to her Heart
Hospital surgeons removed a malignant kidney tumor by cooling her body to stop her circulation, draining her blood, and then removing her cancerous kidney and the remnants of the cancer that had spread to her heart.
Obamas cure is worse than what sickens us. A huge chunk - 20 percent of the uninsured - are uninsured by choice. Another 25 percent qualify for federal coverage but dont enroll. Plus, uninsured non-citizens, including those here illegally, get rolled into the 46 million (the number of uninsured bandied about by pandering politicians).
The agency will broaden a project to study the DNA of tumors to try and find better treatments, Dr. John Niederhuber told a meeting in Denver of the American Association for Cancer research.
|Powered by NeonCRM|